Literature DB >> 25336552

Hypertensive urgency: an important aetiology of rebound hypertension.

John Malaty1, Irene A Malaty2.   

Abstract

A 46-year-old African-American man with a history of hypertension, end-stage kidney disease (on haemodialysis) and previous cocaine misuse presented to the emergency room with a sudden onset of severe headache and diaphoresis without other neurological or cardiovascular signs/symptoms. He checked his blood pressure at home and found it to be 230/130. It did not improve despite taking two serial doses of oral clonidine 0.3 mg. Evaluation with head CT and lumbar puncture demonstrated no acute intracranial process, such as subarachnoid haemorrhage. These symptoms started after he took Libido-Max, an over-the-counter supplement for erectile dysfunction. This supplement includes yohimbine, an α-2 antagonist, which counteracts the effects of oral clonidine, one of his routine antihypertensive medications. This led to rebound hypertension and made his hypertensive urgency resistant to oral clonidine. He was successfully treated with intravenous labetalol and his symptoms quickly resolved after lowering of his blood pressure. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25336552      PMCID: PMC4208112          DOI: 10.1136/bcr-2014-206022

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  High blood pressure. A side effect of drugs, poisons, and food.

Authors:  E Grossman; F H Messerli
Journal:  Arch Intern Med       Date:  1995-03-13

2.  Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.

Authors:  Cyndya Shibao; Luis E Okamoto; Alfredo Gamboa; Chang Yu; Andre' Diedrich; Satish R Raj; David Robertson; Italo Biaggioni
Journal:  Hypertension       Date:  2010-09-13       Impact factor: 10.190

3.  Contrasting actions of pressor agents in severe autonomic failure.

Authors:  J Jordan; J R Shannon; I Biaggioni; R Norman; B K Black; D Robertson
Journal:  Am J Med       Date:  1998-08       Impact factor: 4.965

4.  Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.

Authors:  E Grossman; R F Rea; A Hoffman; D S Goldstein
Journal:  Am J Physiol       Date:  1991-01

5.  The pharmacokinetics of yohimbine in man.

Authors:  J A Owen; S L Nakatsu; J Fenemore; M Condra; D H Surridge; A Morales
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients.

Authors:  E Grossman; T Rosenthal; E Peleg; C Holmes; D S Goldstein
Journal:  J Cardiovasc Pharmacol       Date:  1993-07       Impact factor: 3.105

7.  Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.

Authors:  Pascal Le Corre; Robert J Parmer; Mala T Kailasam; Brian P Kennedy; Todd P Skaar; Herbert Ho; Roger Leverge; Douglas W Smith; Michael G Ziegler; Paul A Insel; Nicholas J Schork; David A Flockhart; Daniel T O'connor
Journal:  Clin Pharmacol Ther       Date:  2004-08       Impact factor: 6.875

  7 in total
  1 in total

1.  Pneumoperitoneum in laparoscopy and preoperative antihypertensive agents: A retrospective study.

Authors:  Hyunjee Kim
Journal:  Exp Ther Med       Date:  2019-10-03       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.